Baker Tilly Wealth Management, LLC Eli Lilly & CO Transaction History

Baker Tilly Wealth Management, LLC

$220 Million
Q3 2024

A detailed history of Baker Tilly Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Baker Tilly Wealth Management, LLC holds 1,131 shares of LLY stock, worth $880,619. This represents 0.46% of its overall portfolio holdings.

Number of Shares

1,131

Previous 1,406 19.56%

Holding current value

$880,619

Previous $1.27 Million 21.31%

% of portfolio

0.46%

Previous 0.53%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$772.14 - $960.02 $212,338 - $264,005	-275 Reduced 19.56%	1,131 $1 Million
Q2 2024 Jul 18, 2024	SELL	$724.87 - $909.04 $1.61 Million - $2.02 Million	-2,217 Reduced 61.19%	1,406 $1.27 Million
Q1 2024 May 09, 2024	SELL	$592.2 - $792.28 $306,167 - $409,608	-517 Reduced 12.49%	3,623 $2.82 Million
Q4 2023 Jan 10, 2024	SELL	$525.19 - $619.13 $20,482 - $24,146	-39 Reduced 0.93%	4,140 $2.41 Million
Q3 2023 Oct 10, 2023	SELL	$434.7 - $599.3 $44,339 - $61,128	-102 Reduced 2.38%	4,179 $2.24 Million
Q2 2023 Jul 20, 2023	SELL	$350.74 - $468.98 $87,685 - $117,245	-250 Reduced 5.52%	4,281 $2.01 Million
Q1 2023 Apr 12, 2023	BUY	$310.63 - $364.82 $462,838 - $543,581	1,490 Added 49.0%	4,531 $1.56 Million
Q4 2022 Jan 26, 2023	SELL	$321.55 - $374.67 $32,798 - $38,216	-102 Reduced 3.25%	3,041 $0
Q3 2022 Oct 20, 2022	SELL	$296.48 - $337.87 $276,022 - $314,556	-931 Reduced 22.85%	3,143 $1.02 Million
Q2 2022 Jul 28, 2022	SELL	$278.73 - $327.27 $557 - $654	-2 Reduced 0.05%	4,074 $1.32 Million
Q1 2022 Apr 27, 2022	SELL	$234.69 - $291.66 $117,814 - $146,413	-502 Reduced 10.97%	4,076 $1.17 Million
Q4 2021 Feb 08, 2022	BUY	$224.85 - $279.04 $26,082 - $32,368	116 Added 2.6%	4,578 $1.27 Million
Q3 2021 Nov 02, 2021	BUY	$221.6 - $272.71 $443 - $545	2 Added 0.04%	4,462 $1.03 Million
Q2 2021 Jul 30, 2021	BUY	$180.55 - $233.54 $7,944 - $10,275	44 Added 1.0%	4,460 $1.02 Million
Q1 2021 Apr 28, 2021	SELL	$164.32 - $212.72 $37,300 - $48,287	-227 Reduced 4.89%	4,416 $825,000
Q4 2020 Feb 03, 2021	BUY	$130.46 - $172.63 $605,725 - $801,521	4,643 New	4,643 $784,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Tilly Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baker Tilly Wealth Management, LLC with notifications on news.

Account

Baker Tilly Wealth Management, LLC Eli Lilly & CO Transaction History